3 Stocks to Buy According to Devesh Gandhi’s SilverArc Capital
In this article, we will discuss the top 3 stocks to buy according to Devesh Gandhi’s SilverArc Capital.
Chinook Therapeutics Inc. (KDNY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 0 | $0 | 0% | |
| 2. | Burrage Capital Management Christiana Goh Bardon | 0 | $0 | 0% | |
| 3. | Vivo Capital Albert Cha And Frank Kung | 0 | $0 | 0% | |
| 4. | Rubric Capital Management David Rosen | 0 | $0 | 0% | |
| 5. | D E Shaw D. E. Shaw | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.00 | 570,000 | Director | 5,161,888 | 2022-05-27 | Filing | |
| $13.03 | 5,000 | Officer, Director | 205,880 | 2022-05-25 | Filing | |
| $14.00 | 1,215,000 | Director | 4,591,888 | 2021-11-15 | Filing | |
| $12.00 | 2,000 | Officer, Director | 109,837 | 2021-09-20 | Filing | |
| $11.98 | 208,500 | Director | 3,376,888 | 2021-08-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.00 | 5,000 | Officer | 5,897 | 2022-08-04 | Filing | |
| $18.09 | 5,000 | Officer | 5,897 | 2022-07-11 | Filing | |
| $15.36 | 5,000 | Officer | 5,897 | 2022-04-11 | Filing | |
| $13.00 | 2,500 | Officer | 5,897 | 2022-02-18 | Filing | |
| $12.74 | 895 | Officer | 22,203 | 2022-02-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Hedge Funds Are Crazy About Chinook Therapeutics, Inc. (KDNY)
A whopping number of 13F filings filed with U.S.
5 Biotech Stocks to Buy Now According to Srini Akkaraju and Michael Dybbs' Samsara BioCapital
In this article, we will discuss 5 biotech stocks to buy now according to Srini Akkaraju and Michael Dybbs' Samsara BioCapital.
Billionaire Hedge Funds
